Where L-leucine is permitted, and what the file must show
L-leucine reaches the EU, US and UK as a food ingredient, and the permission question is rarely the obstacle. The file still has to show which form is sold, which metal limits apply, how the label names it and where the claim boundary sits. The three markets answer those questions with different instruments.
Permission, metal limits, the label name and the claim wording are four different questions, and one market's answer does not carry into another.
Four checks, three markets
An ingredient file answers at least four questions: a permission check (is the substance allowed in this category?), a contaminant check (does the lot meet the maximum levels?), a labelling check (does the pack name the ingredient correctly?) and a claims check (does the wording stay inside the authorised or permitted set?). A file that answers only the first will fail at the border or label review.
Leucine is an amino acid. The EU supplement directive's positive list is built around vitamins and minerals, so leucine travels through general food law and the rules of the member state, not through Annex II. The US uses the dietary-supplement framework, and the UK uses retained food law.
The EU and the UK
Four instruments do most of the work. Regulation (EC) No 178/2002 sets the general food-safety requirement and the traceability duty. Directive 2002/46/EC sets the supplement category, the labelling particulars and any notification route a member state operates. Regulation (EU) No 1169/2011 sets the food-information rules, including the ingredient list. Regulation (EU) 2023/915 sets the contaminant maximum levels.
Because L-leucine is not in Annex I or Annex II to Directive 2002/46/EC, the member state of sale may apply its own rules on amino acids in supplements, including a notification or a restriction. Check that national rule before the artwork is approved, not after.
The label names the ingredient as “L-leucine”; there is no Nutrient Reference Value for an amino acid, so no percentage NRV applies. The supplement also carries the directive's warnings, including the statement not to exceed the stated dose.
In Great Britain the operative texts are the Food Supplements (England) Regulations 2003 (with their devolved equivalents), retained EU food law and the Nutrition and Health Claims (England) Regulations 2007. The outcome is close to the EU position: the ingredient is named, the standard warnings apply, and a health claim has to appear in the GB register.
Northern Ireland sits under the Windsor Framework and applies the EU texts, so a UK-wide launch needs both versions checked.
The United States
L-leucine is a dietary ingredient under the FD&C Act as amended by DSHEA. A supplement that contains it is made under the current good manufacturing practice rules in 21 CFR 111 and labelled under 21 CFR 101.36. There is no pre-market approval, but the GMP rules require identity, purity and composition records, and the label has to declare every dietary ingredient in the Supplement Facts panel.
US federal law sets no maximum for lead, cadmium, mercury or arsenic in dietary supplements. That absence does not remove the adulteration duty; state law can add a warning requirement. California's Proposition 65 is a well-known example, and it applies to exposures, not to a certificate line.
The Supplement Facts panel names “L-leucine” and gives the amount per serving. There is no Daily Value for an amino acid, so no %DV figure belongs beside it. A blend has to list its components, not only a proprietary blend name.
Contaminant limits and the specification
| Parameter | EU maximum level | US federal | UK (GB) | Product specification |
|---|---|---|---|---|
| Lead (Pb) | 3.0 mg/kg in food supplements | No federal maximum level | Retained limit, 3.0 mg/kg | ≤3 mg/kg |
| Cadmium (Cd) | 1.0 mg/kg in food supplements | No federal maximum level | Retained limit, 1.0 mg/kg | ≤1 mg/kg |
| Mercury (Hg) | 0.1 mg/kg in food supplements | No federal maximum level | Retained limit, 0.1 mg/kg | ≤0.1 mg/kg |
| Arsenic (As) | No EU-wide maximum level for total arsenic in supplements | No federal maximum level | No GB-wide maximum level for total arsenic | ≤2 mg/kg |
The EU figures come from Regulation (EU) 2023/915; the annex has product-specific exceptions, so check the current text. The UK column describes the retained GB position and should be rechecked against the current GB text. The product specification is the contractual line: where a legal limit exists, the specification sits at or below that limit, and the lot certificate has to show a result against it.
Microbiology has no EU maximum level for a supplement of this kind; the APC, yeast and mould, E. coli and Salmonella limits are product limits and belong in the buyer's file.
The claim boundary
In the EU, a health claim needs to be authorised under Regulation (EC) No 1924/2006 and listed in the EU Register. As of this review there is no authorised claim for L-leucine, so a pack that carries one is relying on a claim that the register does not support. The same is true in Great Britain under the GB register. A nutrition claim is a separate question and depends on the finished product, not on the leucine line.
In the US, a structure/function claim is permitted without pre-market approval if it is truthful, substantiated and carries the disclaimer required by 21 CFR 101.93; a disease claim is a drug claim and is not available to a supplement. The safe file makes no health claim at all and describes the ingredient, the amount and the form.
The file a buyer should hold
| Document | What it should show |
|---|---|
| Specification | Form, CAS 61-90-5, assay basis, rotation, loss on drying, pH, mesh, metals, micro |
| Certificate of analysis | The lot result against each limit, with methods |
| Safety data sheet | Handling, dust, storage and transport information |
| Manufacturing flow | Route, key process steps and the points that control identity |
| Allergen statement | Allergen cross-contact and the cleaning controls behind the statement |
| GMO and origin statements | GMO status and non-animal origin, where the route requires it |
| Metals and micro reports | The panel behind the certificate, with methods and limits |
A short pre-shipment checklist
- The specification names free L-leucine and CAS 61-90-5, not “leucine”.
- The assay is on the dried basis, and the certificate states the basis.
- The specific rotation is reported with solvent, concentration and temperature.
- The lot meets the destination market's metal limits, with the result on the certificate.
- The label names L-leucine, or every component of the blend.
- No health claim is carried unless it is authorised in the destination market.
The release lines are explained on the COA page, the form question on the grade page, and the tests that prove the L form on the identity page. The market instruments are set out in the EU regulatory note, the US note and the UK note, and the catalog specification is on the product page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation